Skip to main content
Clinical Trials/NCT00279968
NCT00279968CompletedNot Applicable

Investigating Significant ICD Heart Therapies Registry Study (INSIGHTS ICD Registry)

Medtronic Cardiac Rhythm and Heart Failure0 sites1,326 target enrollmentStarted: February 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,326

Study Overview

Brief Summary

The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients 18 years of age or older.
  • Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
  • New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.

Exclusion Criteria

  • Patients enrolled in a device study which effects programming and or treatment.

Investigators

Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Sponsor Class
Industry

Similar Trials